COPHS Faculty Curriculum Vitae
Total Page:16
File Type:pdf, Size:1020Kb
Faculty CVs CURRICULUM VITAE NAME: Cyril V. Abobo DEGREE: Doctor of Pharmacy Florida A & M University College of Pharmacy & Pharmaceutical Sciences Tallahassee, Florida Bachelor of Science/Pharmacy Texas Southern University College of Pharmacy & Health Sciences Houston, Texas ADDITIONAL American Association of Colleges of Pharmacy TRAINING: Fellowship (2004-2005) University of Georgia, College of Pharmacy, Department of Pharmaceutics. Assay development, animal dosing techniques, and pre-clinical studies of anti-retroviral agents. (January - May, 1992) Licensure Texas State Board of Pharmacy Certifications Physical Assessment in Patient Care Management Nova Southeastern University, July 2002. Delivering Medication Therapy Management Services in the Community. American Pharmacists Association, May 2010. Pharmacy Based Immunization Delivery: Certificate Program for Pharmacists. American Pharmacists Association, October, 2011. PROFESSIONAL EXPERIENCE: 1993-Present Associate Professor, Pharmacy Practice Texas Southern University College of Pharmacy and Health Sciences 1993-2008 Part Time/Registry Pharmacist (Inpatient) - Weekends Ben Taub General Hospital Houston, Texas 77030 1988-1993 Assistant Professor, Pharmacy Practice Texas Southern University College of Pharmacy and Health Sciences 1988-Present Clinical Pharmacy Preceptor Texas Southern University College of Pharmacy and Health Sciences Internal/General Medicine Michael E. DeBakey Veterans Affairs Medical Center Houston Texas 1987-88 Clinical staff pharmacist/Clinical Preceptor Ben Taub General Hospital Houston, Texas 77030 1985-86 Lecturer University of Benin School of Pharmacy Benin City, Nigeria 1983-85 Clinical staff pharmacist/Clinical Preceptor Ben Taub General Hospital Houston, Texas 77030 RESEARCH/SCHOLARSHIP Publications Abobo CV, Ma J, Liang D. Effect of menthol on nicotine pharmacokinetics in rats after cigarette smoke inhalation. Nicotine Tob Res. 2012: doi: 10.1093/ntr/ntr287. John J, Robinson K, John M, Caballero J, Ma J, Liang D, Abobo C. Simultaneous LC-MS/MS determination of racemic warfarin and etravirine in rat plasma and its application in pharmacokinetic studies. Book Chapter: “Tandem Mass Spectrometry,” ISBN 978-953- 307-870-0. (in press) Wei B, Abobo CV, Ma J, Liang D. Gender differences on pharmacokinetics of antipyrine in a simulated weightlessness rat model. Aviat Space Environ Med 2012;83:11-6. Abobo CV, Wu L, John J, Joseph MK, Bates TR, Liang D. LC-MS/MS determination of etravirine in rat plasma and its application in pharmacokinetic studies. J Chromatogr B 2010;878:3181-6. Epub 2010 Sep 29. Abobo CV, Wei B, Liang D. Stability of zonisamide in extemporaneously compounded oral suspensions. Am J Health Syst Pharm. 2009;66:1105-9. Abobo CV, and Xian Yongming. Lack of pharmacokinetic interaction between dipyridamole and zalcitabine in rats. Antiviral Res 1997;34:A67. Abobo CV, and Xian Yongming. Lack of pharmacokinetic interaction between dipyridamole and zalcitabine in rats. Cell Mol Biol 1997;43(7):1045-50. Pinon M, McCants E, Egbunike IG, Abobo CV, and Osemene NI. Evaluation of the use of saquinavir in an HIV ambulatory care center. Int Pharm Abstr 1996;33:2286. Nguyen T, and Abobo CV. Rate of phenytoin drug-induced toxicity at a private institution. Int Pharm Abstr 1996;33:2300. Noujedehi MM, Baghaie A, and Abobo C. Correlation between serum creatinine and vancomycin dosing frequency in renal failure patients. Int Pharm Abstr 1996;33:2319. Rowe AL, Abobo CV, Mccants ER, Egbunike I, Akpaffiong MJ, and Okafor KC. Frequency of chart-documented adverse drug reactions in AIDS patients treated in an ambulatory clinic. Int Pharm Abstr 1996;33:2270. Abobo CV, Okafor KC, Ike EN, Rowe AL. HIV disease and opportunistic infections. HGASHP Newsletter 1995;17:1-5. Bailey RE, Abobo CV, Okafor KC, McCants E, Enigbokan M. Monitoring warfarin therapy with the International Normalized Ratio. Int Pharm Abstr 1995;32:2346. Abobo CV, Ni L, Schinazi RF, Liotta DC, Boudinot FD. Pharmacokinetics of 2',3'dideoxy-5- fluoro-3'-thiacytidine in rats. J Pharm Sci 1994;83:96-99 Robbins TJ, Abobo CV. HIV disease and opportunistic infections. US Pharm 1993;18:H10- H24 Okafor KC, Abobo CV. The multidisciplinary approach to chronic pain management. Anesth Today 1992;3:6-10. Okafor KC, Abobo CV. Clinical management of cancer pain. Pract Gastroenterol 1991;15:26-29. Okafor KC, Abobo CV. Clinical management of chronic cancer pain. J Natl Pharm Assoc 1991;35:13-17. Okafor KC, Abobo CV. Formulary Update: Ondansetron, a new antiemetic for chemotherapy induced emesis. Pract Gastroenterol 1991;15:41,45-46. Zenon III GJ, Abobo CV, Carter BL, Ball DW. Potential use of aldose reductase inhibitors to prevent diabetic complications. Clin Pharm 1990;9:446-57. Zenon III GJ, Abobo CV, Carter BL, Ball DW. Potential use of aldose reductase inhibitors to prevent diabetic complications. Am J Hosp Pharm 1990;47:1659-60. (Clin Digest) Cheung LK, Abobo CV, Galley MA. Human (rDNA) insulin allergy in a type II diabetic patient resistant to oral hypoglycemic agents. Int Pharm Abstr 1989;26:489. Maswoswe JJ, Enigbokan M, Felder T, Abobo C et al. Appropriate nutritional assessment in patients prior to the initiation of TPN in four different hospitals: county, government, community, and private. Int Pharm Abstr 1993;30:2550 Presentations: Cheung LK, Abobo CV, Galley MA. Human (rDNA) insulin allergy in a type II diabetic patient resistant to oral hypoglycemic agents. American Society of Hospital Pharmacists Midyear Clinical Meeting, Dallas, Texas, December 1988. (abstr) Cheung LK, Abobo CV, Galley MA. Human (rDNA) insulin allergy in a type II diabetic patient resistant to oral hypoglycemic agents. Texas Society of Hospital Pharmacists 41st Annual Seminar Presentations, San Antonio, Texas, April 1989. (abstr) Owens G, Moss JT, Weber CR, Abobo CV. The development of clinical decision-based dosing algorithm for improving the accuracy of parenteral and oral theophylline usage. American Society of Hospital Pharmacists Midyear Clinical Meeting, Atlanta, Georgia, December 1989. Abobo, CV. Review and update of biotechnology drugs: Therapeutic uses of: Biotechnology Product Conference, Houston, Texas, April 1990. Evans C, Ike E, Abobo CV. Criteria-based H2-receptor antagonists use evaluation in a county hospital. American Society of Hospital Pharmacists Midyear Clinical Meeting, Las Vegas, Nevada, December 1990. Morris CM, Abobo CV, Felder TB. Drug-induced modifications of zidovudine disposition in the rat. American Society of Hospital Pharmacists Midyear Clinical Meeting, New Orleans, Louisiana, December 1991. Abobo CV, Ni L, Schinazi RF, Liotta DC, Boudinot FD. Pharmacokinetics of 2',3'-dideoxy- 5-fluoro-3'-thiacytidine (FTC) in rats. American Association of Pharmaceutical Scientists Annual Meeting, San Antonio, Texas, November 1992. (abstr) Abobo CV. Pharmacology of beta-blockers. Harris County Hospital District continuing education series, Houston, Texas, July 1992. Abobo CV. Pharmacokinetics of 2',3'-dideoxy-5-fluoro-3'-thiacytidine (FTC) in rats. Third RCMI International Symposium, Workshop I: AIDS Biomedical and Clinical Research, Atlanta, Georgia, November 1992. (Podium) Cyril V. Abobo, Kingsley C. Okafor, Husam Ghusn, and Golden J. Zenon III, Treatment of AIDS-Associated Bacillary Angiomatosis with Ciprofloxacin and Rifampin, RCMI International AIDS Symposium, November 3-4, 1994, San Juan, Puerto Rico. Baghaie A, Bayat M, Abobo CV, Zenon III G, Bates TR, The effect of imipenem/cilastatin on acute cyclosporine nephrotoxicity in heart/lung transplant patients, Society of Critical Care Medicine 24th Education and Scientific Symposium, February 3, 1995, San Francisco. Bailey RE, Abobo CV, Okafor KC, McCants E, and Enigbokan M. Monitoring warfarin therapy with the International Normalized Ratio, Annual ASHP Midyear Clinical Meeting and Exhibits, Las Vegas, Nevada, December 3-7, 1995 Abobo, CV and Xian, Yongming. Effect of dipyridamole on the pharmacokinetics of zalcitabine (ddC) in rats. AAPS Tenth Anniversary Annual Meeting and Exposition, Seattle, Washington, October 27-31, 1996 Taylor CT, Abobo CV, Larson RA, Scott VG, Stowe CD, Taft DR. Leadership frame analysis of administrators in academic pharmacy. American Association of Colleges of Pharmacy 2005 Annual Meeting and Seminars, Cincinnati, Ohio, July 9-13, 2005. Kocman B, Taylor J, Abobo C, Milton S. Prevention of antidiabetic agent-induced hypoglycemia in the hospitalized patient: development of a multi-disciplinary tracking sheet. ASHP Midyear Clinical Meeting, Las Vegas, Nevada, December 3-8, 2005. Abobo C, Liang D, Ma J, John JA, Bates TR. Effect of acute etravirine treatment on warfarin disposition kinetics in rats. American Association of Pharmaceutical Scientists Annual Meeting, New Orleans, Louisiana, November 14-18, 2010. (abstr) Abobo C, Wu L, John J, Kizhakkekara M, Bates TR, Liang D. LC-MS/MS determination of etravirine in rat plasma and its application in pharmacokinetic studies. American Association of Pharmaceutical Scientists Annual Meeting, New Orleans, Louisiana, November 14-18, 2010. (abstr) Formulary Reviews and Drug Monographs Ben Taub General Hospital (Pharmacy and Therapeutics Committee) - 1985, 1987-88 Grants/Contracts Felder TB, Abobo CV (co-investigator). Drug-induced modifications of AZT disposition in the rat. Granted by AMHPS AIDS Consortium: $9,000. Grant #5P20 AI29360-03S1. Faculty development grant at the University of Georgia, Department of Pharmaceutics. Granted by RCMI: $37,189. Lewis III H (Principal investigator),